Physician profile
Jacob Roberts
NPI 1831218817
$30,284.33
in general payments reported to CMS, 2019-2025
7 companies · $8,500 in 2025
The $8,500 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $11.10 · 2022: $32.71 · 2023: $7,885 · 2024: $1,776 · 2025: $8,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Food and Beverage: $2,464 · Travel and Lodging: $1,688 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $14,000.00 |
| Food and Beverage | $2,464.22 |
| Travel and Lodging | $1,688.13 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,482.95 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $9,328.77 | 2019-2024 | Gore Synecor Biomaterial, Seamguard, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Medtronic, INC. | $158.52 | 2022-2024 | Signia |
| Ethicon US, LLC | $148.68 | 2019-2025 | Echelon; Endopath |
| Covidien LP | $134.80 | 2019-2020 | |
| Tela Bio, INC. | $17.46 | 2019 | |
| Novo Nordisk INC | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.